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Aiming to discern the mechanisms by which circulating
glycatedalbuminalterstheglomerularﬁltrationproperties
thatleadtoglomerulardysfunctionindiabetes,theauthors
studied the distribution and densities of anionic charges
through the rat glomerular wall upon intravascular infu-
sionofAmadoriproducts,aswellasinvariousconditionsof
increased glomerular permselectivity. Polylysine-gold was
used as the probe to reveal the anionic charges. The study
was carried on renal tissue sections of bovine serum al-
bumin (BSA)- and glycated BSA–injected, normoglycemic
animals. Results were generated through morphometrical
evaluations of the gold labeling. Changes in glomerular an-
ionicdistributionwerecorroboratedonrenaltissuesections
of short- and long-term diabetic rats and of normal new-
bornrats,situationsknownforabnormalglomerularﬁltra-
tion. Altered renal function in these conditions was clearly
associated with changes in glomerular anionic charges. On
theotherhand,theinfusionofglycatedalbumininthecircu-
lation of normal rats, though altering glomerular ﬁltration
properties, did not modify the distribution and density of
the polylysine-gold labeling through the glomerular base-
ment membrane. Thus, anionic charges seem not to be the
factor involved in the early changes of glomerular perme-
ability induced by circulating glycated albumin.
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The glomerular basement membrane (GBM) restricts the
passage of plasma proteins according to their size, charge,
and molecular conformation [1, 2]. Several studies have pro-
posed that the lamina densa [3–5] and/or the slit diaphragms
between podocytes [6, 7] could be responsible for the size-
restrictive properties of the barrier. The restriction by charges
in the glomerular wall has been attributed, on the other hand,
to the presence in the basement membrane of anionic structural
components,suchasthesulphatedglycosaminoglycansinhep-
aran sulphate proteoglycans (HSPGs), reviewed in [8], and the
carboxylgroupsinglycosaminoglycansandsialoproteinsinthe
GBM and the epithelial glycocalyx [9, 10].
In previous studies, we have reported that glycated albu-
min, once in circulation, penetrates the glomerular wall of nor-
mal animals deeper than nonglycated albumin and reaches the
glomerular urinary space [11]. Moreover, even in normal ani-
mals, glycated albumin alters the glomerular ﬁltration proper-
ties of other serum proteins [11, 12]. These alterations encoun-
tered in normal animals were found to be transient and lasted
up to 48 hours after the introduction of glycated albumin in
circulation [12]. No particular accumulation of the tracer was
observed in the GBM or the mesangial matrix of infused ani-
mals [11]. The mechanisms by which glycated albumin modi-
ﬁes the glomerular ﬁltration properties can be multiple, among
others, glycated albumin could affect the anionic charges of
the glomerular wall and/or the size of GBM pores. Indeed,
changes in anionic charges in the GBM have been reported as
likely responsible for the protein leakage and proteinuria oc-
curringduringdiabetes[13–17].Isogaiandcolleagues[4]have
demonstrated that loss of glomerular anionic charges in exper-
imental animals could be detected as early as 2 weeks after
streptozotocin (STZ)-induced hyperglycemia. Along this line,
increased glomerular permeability to endogenous albumin was
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reported to take place upon 10 days of hyperglycemia, and this
without any evident changes in the structure of the GBM [18].
Persistent hyperglycemia is responsible for early glycation of
circulating and structural proteins (Amadori adducts) [10, 19],
which are abundant in early diabetes [20]. The participation of
these modiﬁed proteins and their very active reaction products
or advanced glycated end products (AGEs) in the initiation and
progression of diabetic nephropathies has already been demon-
strated [20–22]. It has previously been shown that glycated al-
bumin is a major trigger in the onset of glomerular dysfunction
and proteinuria occurring in diabetic condition [11, 12, 23, 24].
Because glycated albumin is able to alter the glomerular
permeability [11, 12], we decided to investigate if circulating
glycated albumin alters the glomerular permselectivity prop-
erties by modifying the density and distribution of anionic
charges across the GBM. Evaluation of anionic charges in the
glomerular wall has been previously addressed by means of
cationic probes, such as ruthenium red, alcian blue, colloidal
iron, polylysine, and polyethyleneimine, combined with spe-
ciﬁc enzymatic treatments [16, 25–29]. These studies have al-
lowed for the localization and identiﬁcation of anionic charges
in the GBM and revealed changes occurring in different patho-
logical situations [25–28]. We have chosen to work with the
polylysine-goldprobe[30],whichhasbeenshowntoefﬁciently
reveal anionic charges over the glomerular wall, with high res-
olution, in normal as well as in experimental and pathological
conditions [31]. Being particulate, this probe allows for quan-
titative determinations of densities and spatial distribution of
the labeling [32], which is particularly useful in establishing
changes occurring in experimental conditions.
Tocorroboratetheeffectivenessofthepolylysine-goldprobe
and better understand the involvement of anionic charges into
the overall establishment of glomerular permselectivity prop-
erties in the GBM, we applied the same polylysine-gold ap-
proach to 2 additional conditions displaying altered glomerular
function: (1) during development, at a time point where the
permeability properties of the glomerular wall have yet to be
established; and (2) in short- and long-term diabetes, in which
glomerularﬁltrationpropertiesundergoprogressivealterations.
Results obtained indicate that although alterations in
glomerular ﬁltration properties parallel changes in anionic
charges distribution and density during development and dia-
betes,infusionofglycatedalbumin,thoughmodifyingﬁltration
properties, seems not to affect glomerular anionic charges.
MATERIALS AND METHODS
Animals
Adult male Sprague-Dawley rats weighing 100 to 150 g at
the beginning of the experiment were used. In addition, 4-day-
oldratswerealsoincludedinthestudy.Diabeteswasinducedin
adultratsbyasingleintraperitonealinjectionofSTZ,70mg/kg
body weight, freshly dissolved in 10 mmol/L sodium citrate
buffer, pH 4.5. All rats were maintained on standard chow diet
andtapwateradlibitumforthelengthoftheexperiment.Noin-




Animals were separated in 7 groups:
(a) Normaladultrats(n=3)injectedintravenouslywith50mg
of glycated bovine serum albumin (BSA) [11], a modiﬁed
form of circulating albumin predominant in early diabetic
subjects [21]. The glycated BSA was prepared according
to previously described procedures [11].
(b) Normaladultrats(n=3)injectedintravenouslywith50mg
of BSA.
(c) Hyperglycemic (26.7±1.2 mmol/L) young adult rats
(n=3), 10 days after STZ injection, which have demon-
strated increased glomerular permeability [18] and high
levels of circulating glycated albumin [21].
(d) Age-matched normoglycemic controls (n=3).
(e) Long-term hyperglycemic (31.2±1.2 mmol/L) adult rats
(n=3), 8 to 12 months after STZ injection, presenting the
characteristic features of diabetic nephropathy (glomerular
hypertrophy,thickenedbasementmembranes,polyuria,and
proteinuria).
(f) Age-matched (12 months old) normoglycemic controls
(n=3).
(g) Normoglycemicanimals(n=3),4daysold,stageatwhich
GBM development is not completed and glomerular perm-
selectivitypropertieshavenotyetbeenestablished[33,34].
For tissue sampling, animals were anesthetized with an in-
traperitonealinjectionofurethaneandtheabdominalcavitywas
opened.Theﬁxative,1%glutaraldehydein0.1mol/Lphosphate
buffer, pH 7.2, was ﬂooded into the abdominal cavity to begin
the ﬁxation in situ. After 10 minutes, a slice of renal cortex was
sampled,cutinsmallpieces,andimmersedinthesameﬁxative
for 2 hours at room temperature. Tissues were then dehydrated
in cold graded methanol and embedded in Lowicryl at −20◦C.
For the animals in groups a and b, the albumin was injected in
the cava vein and kept in circulation for 30 minutes [11] prior
to ﬁxation and processing as described above.
Cytochemical Labeling
In order to reveal the anionic sites in the glomerular wall,
labeling with a polylysine-gold complex was performed andGLYCATED ALBUMIN AND GLOMERULAR ANIONIC CHARGES 85
the results evaluated by morphometrical determinations. Poly-
L-lysine (350,000 molecular weight; Sigma, Toronto, ON) was
tagged to 10- or 15-nm gold particles, as previously described
[30, 31]. Labeling was performed on ultrathin renal tissue
sections by ﬂoating them on a drop of 150 mmol/L glycine
in phosphate-buffered saline (PBS), pH 7.2, for 15 minutes,
then on a drop of polylysine-gold diluted in PBS, pH 7.2, or
in KCl, 50 mmol/L pH 2.0, for 30 minutes. The grids were
washed with distilled water, dried, and stained with uranyl ac-
etate. In order to identify the glomerular wall components con-
tributingtopolylysine-goldlabeling,enzymaticdigestionswith
neuraminidase (from Clostridium perfringes, 1 U/mL; Sigma)
or heparitinase (from Flavobacterium heparinum, 130 U/mL;
Sigma), was performed for 1 hour at 37◦C [31], prior to the
labeling protocol. As a further control, grids were preincubated
with untagged polylysine for 30 minutes before performing the
labeling protocol.
Morphometrical evaluation of the labeling was carried out
with a Zeiss Videoplan image analysis system (Carl Zeiss, Don
Mills, ON). For labeling distribution, distances between each
gold particle and the endothelial abluminal plasma membrane
(A)andbetweentheendothelialandtheepithelialplasmamem-
branes (B) were recorded; the ratio (R = A/B) was calculated.
These ratio values varied between 0 (gold particle located adja-
cent to the endothelial plasma membrane) and 1 (gold particle
adjacent to the epithelial plasma membrane). Results are pre-
sented as histograms and the mean ratio value for each group
was calculated. Densities of polylysine-gold labeling were de-
termined by direct planimetry and gold particle counting and
expressed as number of gold particles per square micrometer.
Only areas displaying transversal sections of the glomerular
wall,clearlyshowingslitdiaphragmsbetweenpodocytes,were
selected for the study. The evaluation was performed on digi-
talized images (recorded on video) at a ﬁnal magniﬁcation of
×154,000. The total area evaluated for labeling densities was
about 30 µm2 for each animal. Concerning labeling distribu-
tions through the GBM, between 700 and 1000 gold particles
were recorded for each animal. These data were derived from
3 different glomeruli per animal. Statistical assessments for the
distributions were performed using the nonparametrical Mann-
Whitney and the Kolmogorov-Smirnov tests. Densities of la-




was obtained over plasma membranes as well as in some intra-
cellularcompartmentsofalmostallrenalcelltypes,particularly
in endothelial, distal, and collecting tubular epithelial cells. All
basementmembranes(glomerular,mesangial,andtubularbase-
ment membranes) were heavily labeled. In the glomerulus, the
luminal surface of the visceral epithelial cells or podocytes and
the luminal surface of endothelial cells were delineated by gold
particles, whereas the plasma membranes of mesangial cells
showed no or sparse labeling. The GBM was labeled by gold
particles, which were rather concentrated on the epithelial side.
The efﬁciency and speciﬁcity of the labeling obtained with
the polylysine-gold probe were assessed through various ex-
perimental conditions. Applying the polylysine-gold at pH 7.2
led to a rather sporadic staining at the level of the plasma
membranes, the cell cytoplasm, and the basement membranes
(Figure 1a). These results resemble those reported under the
samelabelingconditionsbyGoodeandcolleagues[10].Apply-
ing the polylysine-gold at pH 2.0, as reported previously [31],
thelabelingdisplayedamorerestricteddistribution,withselec-
tive intense decoration of the plasma membranes (Figure 1b).
The cell cytoplasm remained rather free of labeling. The GBM
was intensely labeled with a concentration of the gold particles
towardsthelaminaexterna(subepithelialside)(Figure1b).The
treatment of tissue sections with heparitinase prior to labeling
with polylysine-gold led to the extraction of labeling sites of
the GBM (Figure 1c), indicating that polylysine-gold binds to
heparan sulphate proteoglycans. Conversely, treating the tissue
sections with neuraminidase removed all plasma membrane
labeling (Figure 1d), indicating that polylysine-gold binds to
sialic acid residues at this location. GBMs remained labeled af-
terneuraminidasetreatment,suggestingaminimalcontribution
of sialic acid–containing glycoproteins to the anionic charges
of the GBM. Finally, by pretreating the tissue sections with
polylysine prior to labeling with the polylysine-gold complex
abolished all signals (Figure 1e), further supporting the speci-
ﬁcity of the results. Thus, and as reported previously [31], we
proceeded working at pH 2.0.
Normoglycemic animals injected with BSA (Figure 2) as
well as those injected with glycated BSA (Figure 3) showed
similar polylysine-gold labelings in glomerular cell plasma
membranes and in the GBM, with high intensities in the subep-
ithelial side. Upon morphometrical evaluations, GBM labeling
distribution histograms obtained for these 2 groups of animals
were quite similar. In both cases, the GBM labeling displayed
an asymmetrical right-sided distribution (Figures 2b and 3b).
Mean R values were not signiﬁcantly different (0.77±0.01
for the BSA-injected versus 0.76±0.01 for the glycated BSA–
injected animals). GBM labeling densities were also similar
for both groups (188±4 gold particles/µm2 for the BSA-
injected versus 182±6 gold particles/µm2 for the glycated
BSA–injected rats). Tissues from normal noninjected adult rats
(Figure4)displayedGBMlabelingpatternssimilartothoseob-
tained on tissues of BSA-injected animals. The GBM labeling86 I. LONDO˜ NO ET AL.
FIGURE 1
Polylysine-gold labeling on the glomerular wall of normal
rats. (a) Polylysine-gold in PBS, pH 7.2. Gold particles are
sporadically located in the cytoplasm of epithelial podocytes
(P) and endothelial cells as well as through the glomerular
basement membrane (GBM). Polylysine-gold, 10 nm.
(b) Polylysine-gold in KCl, pH 2.0. An intense labeling by
gold particles decorates the P plasma membrane. It is also
abundant on the epithelial side of the GBM and sparse on
the subendothelial side. Polylysine-gold, 10 nm.
(c) Preincubation with heparitinase followed by
polylysine-gold complex, pH 2.0. Labeling is restricted to the
(P) plasma membrane. Only very few gold particles are found
on the GBM. Polylysine-gold, 15 nm.
distribution histograms showed a prominent peak on the right
with a mean R value of 0.76±0.01 (Figure 3b). GBM la-
beling densities were, however, slightly lower (159±6 gold
particles/µm2). Thus, the presence of BSA or glycated BSA in
circulation seems not to affect the pattern of distribution of the
anionic charges across the GBM.
For the short-term hyperglycemic rats (10 days after STZ
injection), which have demonstrated alterations in glomerular
permselectivity [18], the polylysine-gold labeling was also lo-
cated on the subepithelial side of the GBM (Figure 5), though
occupying a wider region than that of the age-matched con-
trol rats (Figure 4). In fact, the histograms revealed a shift of
the labeling towards the center of the GBM (Figures 4b and
5b). Mean R values for these 2 groups of animals differed sig-
niﬁcantly (0.64 ± 0.01 for the hyperglycemic animals versus
0.76±0.01fortheage-matchedcontrols; P <.05).GBMlabel-
ing densities were in the same range, though slightly higher for
the hyperglycemic young animals (178±6 gold particles/µm2
versus 159±6 gold particles/µm2; P <.05).
Long-term hyperglycemic animals (8 to 12 months after
STZinjection)displaycharacteristicdiabeticnephropathywith
thickeningoftheGBM,increasedglomerularpermeability,and
proteinuria [1]. The labeling distribution in the GBM of these
diabetic rats was signiﬁcantly altered compared to their age-
matched controls (Figures 6 and 7). Gold particles were dis-
tributed throughout the GBM (Figure 7). The corresponding
GBM labeling histograms displayed a rather homogenous dis-
tribution (Figure 7b), which contrasts with the asymmetric dis-
tribution of the labeling obtained for the age-matched control
group(Figure6b).Meanratio(R)valueforthediabeticanimals
was signiﬁcantly lower than that of their age-matched control
animals(0.60±0.01versus0.73±0.01; P <.05).Ontheother
hand, GBM labeling densities of diabetic animals were signif-
icantly lower compared to their age-matched control (66±2
gold particles/µm2 versus 81±3 gold particles/µm2). Interest-
ingly, GBM labeling densities among normoglycemic animals
varyalongwithage,withlowervaluesforolderanimals(81±3
versus 159±6 gold particles/µm2).
In immature glomeruli of the 4-day-old rats, character-
ized by nonfused basement membranes, labeling was located
←
(d) Preincubation with neuraminidase followed by
polylysine-gold complex, pH 2.0. Gold labeling is restricted
to the GBM, the (P) plasma membrane being
completely negative. Polylysine-gold, 15 nm.
(e) Preincubation with untagged polylysine followed by
polylysine-gold complex, pH 2.0. Labeling is completely
abolished in all locations. Polylysine-gold, 15 nm. CL,
capillary lumen; En, endothelial cell; P, podocyte; US,
urinary space. Magniﬁcations: ×30,000 (a); ×28,000 (b, e);
×32,000 (c); ×26,000 (d).GLYCATED ALBUMIN AND GLOMERULAR ANIONIC CHARGES 87
FIGURES 2 and 3
Polylysine-gold labeling on the glomerular wall of normal rats injected with either BSA (2a) or glycated BSA (3a). Over the
glomerular basement membrane (GBM), the labeling by gold particles is concentrated on the subepithelial side. Histograms
reveal similar GBM labeling distributions in both conditions, with a single peak on the right side, and similar mean R values
(2b,3 b). CL, capillary lumen; P, epithelial podocytes; US, urinary space. Polylysine-gold, 10 nm. Magniﬁcations: ×38,000 (2a);
×41,000 (3a).
on the individual basement membranes along the endothe-
lial and epithelial sides (Figure 8). In more mature glomeruli
in the same tissue, displaying fused basement membranes,
the GBM labeling was mainly located in the subepithelial
area, with few gold particles on the central and subendothe-
lial parts (Figure 9). Histograms obtained through the morpho-
metrical evaluations revealed a rather uniform labeling distri-
bution for the nonfused GBM (R =0.56±0.01, Figure 8b),
similar to the histograms obtained in other conditions of al-
tered permeability (Figures 5b and 7b). A more asymmet-
rical labeling distribution, with 1 peak on the subepithe-
lial side (R =0.64±0.01; Figure 8b), was obtained for the
more mature glomeruli with fused GBM, approaching the sit-
uation encountered in young adult normoglycemic animals
(Figure 4b).
DISCUSSION
In the present study, the polylysine-gold probe was used
for revealing and analyzing the distribution of anionic charges
across the GBM of normoglycemic rats infused with gly-
cated albumin, which was reported to alter glomerular per-
meability.Otherrelatedexperimentalconditions,characterized
by increased glomerular permeability, were also evaluated in
parallel.
In tissues of normal adult animals, anionic charges are
mainly found along the plasma membrane of most renal cells
and over all basement membranes. In what concerned the
GBM, responsible for the permselectivity of the glomerular
wall, charges revealed by the polylysine probe were located in
the lamina rara externa, and to a lesser extent in the lamina
densa and the lamina rara interna, a pattern similar to that re-
ported with other cationic tracers, such as cuprolinic blue [35].
Based on speciﬁc enzymatic treatments, anionic charges rec-
ognizedbythepolylysine-goldcorrespondtoheparan-sulphate
proteoglycans in the GBM and to sialoproteins in epithelial
andendothelialplasmamembranes[31].Goodeandcolleagues
[10] and Karasawa and colleagues [36] have demonstrated
thatpolylysine-goldcomplexesalsorecognizecarboxylgroups
in chondroitin-sulphate glycosaminoglycans, which have been88 I. LONDO˜ NO ET AL.
FIGURES 4 and 5
Polylysine-gold labeling on the glomerular wall of short-term hyperglycemic rats and their controls. In control rats, labeling over
the GBM is mainly located on the subepithelial side, with few particles in the center and the subendothelial side (4a). The
histogram reveals a single peak of labeling at the right subepithelial side (4b). Tissues from the short-term hyperglycemic rats
(10 days after streptozotocin injection) present a subepithelial labeling of the GBM, but the gold particles spread in a wider
region (5a). The histogram displays lower values on the right side of the distribution (5b). CL, capillary lumen; P, epithelial
podocytes; US, urinary space. Polylysine-gold, 10 nm. Magniﬁcation: ×25,000 (4a); ×32,000 (5a).
shown to contribute in a signiﬁcant manner to the integrity of
the glomerular wall [9].
In previous studies, we as well as others have shown that
glycated albumin introduced in the circulation of normal ani-
mals can alter the glomerular ﬁltration properties [11, 12, 23].
IntroductionofglycatedBSAinnormalanimalsinducesatran-
sient glomerular alteration that lasts for 48 hours [12]. Changes
in glomerular permeability induced by glycated albumin can
hardly be due to levels of protein injected because same quanti-
ties of native BSA were unable to modify the glomerular perm-
selectivity properties [11]. The albumin injected that traverses
the GBM is reabsorbed by proximal tubules and the quantities
excreted in urine are too small to be detected or to induce mea-
surable differences. On the other hand, this method was shown
to be able to detect changes in GBM permeability [11, 12].
The glycated albumin used in our experiments has been
prepared in vitro and contains 1 to 3 modiﬁed lysyl residues
(fructosyllysine) [11]. This modiﬁcation renders the protein
slightly heavier and more anionic than the native one. How-
ever, this modiﬁed albumin, once introduced in the circulation
ofnormalanimals,penetratesdeeperthantheGBMandreaches
the glomerular urinary space [11], altering also the ﬁltration
properties for other circulating molecules [11, 12] that are nor-
mally restrained by the lamina rara interna [3]. Surprisingly,
in the present study, we found that although major alterations
in the glomerular permselectivity took place upon introduction
of glycated albumin in circulation, no changes in the anionic
charge concentration and distribution across the GBM occur,
suggesting that glycated albumin bypass the glomerular perm-
selectivity barrier by mechanisms that do not affect the anionic
charges of the GBM.
In contrast, changes in the concentration and distribution
of anionic charges were recorded in tissues of long-term dia-
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FIGURES 6 and 7
Polylysine-gold labeling on the glomerular wall of long-term hyperglycemic rats and their age-matched controls. In old control
rats, labeling over the GBM is similar to the one observed in younger animals, with numerous gold particles on the subepithelial
side and few throughout the GBM (6a). The GBM labeling histogram reveals a single peak at the right subepithelial side (6b).
Long-term hyperglycemic rats, on the other hand, present a labeling scattered throughout the GBM (7a), which yields a rather
homogeneous distribution, with low R values (7b). Notice that GBM thickness is signiﬁcantly increased in tissues of diabetic
animals (7a). On the other hand, GBM thickness in normoglycemic animals also varies with age (compare 4a with 6a). CL,
capillary lumen; P, epithelial podocyte; US, urinary space. Polylysine-gold, 15 nm. Magniﬁcation: ×32,000 (6a); ×36,000 (7a).
labeling by polylysine-gold complexes decreased and shifted
towards the lamina densa and the lamina rara interna of the
GBM.Suchalterationsinthedistributionoftheanioniccharges
parallel the loss of glomerular permselectivity properties. Sev-
eral parameters can be responsible for these changes, among
them the deposition of circulating proteins [37], including gly-
cated products and AGEs [22, 38], and modiﬁcations of struc-
tural components by glycation [13, 19, 38]. The decrease in
the “de novo” synthesis of sulphate-rich proteoglycans in hy-
perglycemic conditions, the undersulfonation of HSPG, the de-
polymerization of heparan sulphate, and the generation of re-
active oxygen species, have also been suggested as possible
mechanisms involved in the pathophysiological events leading
to diabetic nephropathy (reviewed in [8]).
In short-term diabetic rats, the alteration in glomerular per-
meability was demonstrated as early as 10 days after the onset
ofhyperglycemia[18].Intheserats,themorphologicalfeatures
of the GBM were indistinguishable from those of control an-
imals, although the distribution of anionic charges across the
GBM was altered in a pattern similar to that found for the long-
term diabetic animals. These results go along with those of
Moriya and colleagues [17] and Isogai and colleagues [4] who
demonstratedchangesinpolyethyleneiminebindingsitesinthe
GBM of 1- and 2-week hyperglycemic animals, respectively.
Thus overall, changes in GBM anionic charge distribution in
hyperglycemic animals appear to coincide with impairments in
permselectivity properties.
Along the same line, we studied GBM anionic charges in
a situation when glomerular permeability is not yet efﬁciently
established. Indeed, the embryonic development of glomerular
tissue in 4-day-old rats is not yet fully completed. In such a sit-
uation,thedistributionofanionicchargeswasfoundtobequite
different from that of adult animals due to the fact that the as-
sembly of extracellular matrix components, which contributes
totheestablishmentofthepermselectivitypropertiesandtothe
selective restriction of serum proteins, was not completed [33,
39, 40]. By means of cationic dyes, Reeves and colleagues [34]
haveshownarandomdistributionoftheglycosaminoglycansin90 I. LONDO˜ NO ET AL.
FIGURES 8 and 9
Polylysine-gold labeling on glomeruli of 4 days old rats. Labeling is located along the nonfused endothelial and epithelial
glomerular basement membranes (8a) of immature glomeruli (capillary loop stage) and follows the individual basement
membranes. Morphometrical evaluation of this labeling revealed a rather homogenous distribution across the glomerular wall
basement membranes (8b). In more mature glomeruli of the same kidney, where the basement membranes have fused, the
labeling appears more concentrated on the subepithelial side, with some gold particles in the center and subendothelial side (9a).
The GBM labeling histogram, in this case, shows increasing values towards the right side (9b). CL, capillary lumen; En,
endothelial cell; Ep, epithelial cell; US, urinary space. Polylysine-gold, 15 nm. Magniﬁcation: ×29,000 (8a); ×27,000 (9a).
the GBM at early developmental stages. Using the polylysine-
gold tracer, we have located the anionic charges along the two
distinct extracellular matrix layers corresponding to the imma-
ture nonfused endothelial and epithelial GBMs. This particular
distribution goes along with our results showing that, at this
sameearlystageofmaturation,theselectivepermeabilityprop-
ertiesoftheglomerularwallarenotyetestablishedandalbumin
escapes easily toward the urinary space [33].
These results in newborn and in diabetic animals conﬁrm
the importance of the anionic charges in the proper glomeru-
lar function and the pertinence of the polylysine-gold probe in
revealing their changes. Thus, our experiment with glycated al-
bumin represents a very peculiar situation in which alteration
in glomerular permeability occurs while concentration and dis-
tribution of the anionic charges remain unchanged.
Becauseglycatedalbumindoesnotseemtoaffecttheanionic
charges of the GBM, studies related to the other factors gov-
erningtheglomerularpermselectivitybecomeimminent.Struc-
turalchangesintheglycatedalbuminmoleculeitselfhavebeen
proposed to explain its altered handling by the GBM [11, 12,
23, 24]. In fact, Shaklai and colleagues [41] have demonstrated
that glycation induces conformational changes in serum albu-
min, concomitant to changes in biological properties. That pro-
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a determinant factor for glomerular permselectivity has been
established from studies using dextrans [1], Ficoll [42], and
proteins with similar Stokes-Einstein radius, but with different
physicochemical characteristics [42, 43]. On the other hand,
it has also been proposed that glycated proteins could induce
the release of mediators that would affect vascular properties
[43–45] and likely, glomerular ﬁltration [15].
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